Herpes Zoster Ophthalmicus Secondary to Platelet-Rich Plasma Therapy: A Case Report

The document presents a case of a 71-year-old woman who developed a skin infection called herpes zoster ophthalmicus (HZO) after receiving platelet-rich plasma (PRP) therapy for androgenetic alopecia (AGA), a common type of hair loss. The case underscores the potential for serious side effects like HZO if PRP therapy is not properly administered. The patient's condition improved after treatment with antibiotics and antivirals. The authors stress the importance of following guidelines and safe protocols in PRP therapy to avoid adverse effects, and the need for early diagnosis and immediate management of HZO to prevent severe outcomes such as vision loss.